Nirmidas Biotech
Nirmidas has developed a breakthrough plasmonic gold (pGOLD?) platform that can enhance fluorescence up to 100x for research and diagnostics applications. We have also developed the first commercially available near-infrared II (NIR-II) dye with high biocompatibility. With these technological advancements, Nirmidas aims to personalize healthcare and redefine diagnostics.
Member count: 1-10
Total raised: $7M

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
18.08.2014Seed$2M-Nirmidas B...

Mentions in press and media 2

18.08.2014Nirmidas B...The science comes from the lab...--medcitynew...
18.08.2014Nirmidas B...Nirmidas Biotech, Inc., a